AvenCell to Present New Data from Universal Switchable CAR T Cell Therapy Programs at 65th American Society of Hematology Annual Meeting and Exposition

Poster presentation of updated safety and efficacy data for AVC-101 in relapsed/refractory acute myeloid leukemia, providing clinical proof of concept with best-in-class efficacy signal in late-line AML patients, demonstrating rapid CAR T cell on-off control mechanism of Universal Switchable CAR platform, and impressive durability of responses Poster presentation of preclinical functional characterization and optimization of […]